Topic Hub
8 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 8 of 8 clinical reviews.
A clinician-reviewed guide to the regulatory and compounding status of Prometrium (micronized progesterone), including FDA approval history, current label indications, and the legal framework for compounded progesterone.
Read clinical reviewA clinical comparison of how the FDA and EMA regulate Prometrium (micronized progesterone), including approval history, labeling differences, post-market surveillance, and prescribing implications for HRT.
Read clinical reviewA detailed review of Prometrium (micronized progesterone) safety signals in the FDA Adverse Event Reporting System (FAERS), including reporting trends, label warnings, and how post-market surveillance data compare with clinical trial findings.
Read clinical reviewA complete regulatory history of Prometrium (micronized progesterone), covering FDA approval dates, label changes, safety signals, and clinical trial evidence from PEPI to current prescribing guidance.
Read clinical reviewA clinical review of Prometrium (micronized progesterone) regulatory approvals worldwide, including FDA history, EMA status, Health Canada authorization, label requirements, and post-market safety data.
Read clinical reviewA complete regulatory history of Prometrium (micronized progesterone) label changes from 2020 through 2026, covering FDA safety communications, updated warnings, dosing guidance, and post-market surveillance findings.
Read clinical reviewA clinical review of Prometrium's FDA approval history, patent disputes, generic micronized progesterone competition, and ongoing label and safety considerations.
Read clinical reviewFDA history of Prometrium (micronized progesterone), current label details, post-market safety data, and emerging next-generation progesterone delivery systems in clinical development.
Read clinical review